SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

L773:0959 4973
 

Search: L773:0959 4973 > Uppsala University > Bergquist Jonas > Intracellular conce...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells.

Berglund, Erik (author)
Karolinska Institutet
Ubhayasekera, Sarojini J.K.A. (author)
Karolinska Institutet,Uppsala universitet,Analytisk kemi,Science for Life Laboratory, SciLifeLab
Karlsson, Fredrik (author)
Karolinska Institutet
show more...
Akcakaya, Pinar (author)
Karolinska Institutet
Aluthgedara, Warunika (author)
Uppsala universitet,Analytisk kemi,Science for Life Laboratory, SciLifeLab
Ahlen, Jan (author)
Endocrine and Sarcoma Surgery Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet AND Department of Breast and Endocrine Surgery, Karolinska University Hospital
Fröbom, Robin (author)
Karolinska Institutet
Nilsson, Inga-Lena (author)
Karolinska Institutet
Lui, Weng-Onn (author)
Karolinska Institutet
Larsson, Catharina (author)
Karolinska Institutet
Zedenius, Jan (author)
Karolinska Institutet
Bergquist, Jonas (author)
Uppsala universitet,Analytisk kemi,Science for Life Laboratory, SciLifeLab
Bränström, Robert (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2014
2014
English.
In: Anti-Cancer Drugs. - 0959-4973 .- 1473-5741. ; 25:4, s. 415-22
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Gastrointestinal stromal tumor (GIST) is the most common mesenchymal neoplasm in the gastrointestinal tract. In most GISTs, the underlying mechanism is a gain-of-function mutation in the KIT or the PDGFRA gene. Imatinib is a tyrosine kinase inhibitor that specifically blocks the intracellular ATP-binding sites of these receptors. A correlation exists between plasma levels of imatinib and progression-free survival, but it is not known whether the plasma concentration correlates with the intracellular drug concentration. We determined intracellular imatinib levels in two GIST cell lines: the imatinib-sensitive GIST882 and the imatinib-resistant GIST48. After exposing the GIST cells to imatinib, the intracellular concentrations were evaluated using LC-MS (TOF). The concentration of imatinib in clinical samples from three patients was also determined to assess the validity and reliability of the method in the clinical setting. Determination of imatinib uptake fits within detection levels and values are highly reproducible. The GIST48 cells showed significantly lower imatinib uptake compared with GIST882 in therapeutic doses, indicating a possible difference in uptake mechanisms. Furthermore, imatinib accumulated in the tumor tissues and showed intratumoral regional differences. These data show, for the first time, a feasible and reproducible technique to measure intracellular imatinib levels in experimental and clinical settings. The difference in the intracellular imatinib concentration between the cell lines and clinical samples indicates that drug transporters may contribute toward resistance mechanisms in GIST cells. This highlights the importance of further clinical studies to quantify drug transporter expression and measure intracellular imatinib levels in GIST patients.

Subject headings

NATURVETENSKAP  -- Kemi -- Analytisk kemi (hsv//swe)
NATURAL SCIENCES  -- Chemical Sciences -- Analytical Chemistry (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view